Antimicrobial Growth Promoter Ban and Resistance to Macrolides and Vancomycin in Enterococci from Pigs

2001/11/01 by P. Boerlin, Patrick Boerlin, A. Wissing +5 · 1 citation
Medicine · Biochemistry, Genetics and Molecular Biology · #Antimicrobial Resistance in Staphylococcus #Surgical site infection prevention #Microbial Metabolism and Applications

paper · doi:10.1128/jcm.39.11.4193-4195.2001

Abstract

Ninety-six enterococcus isolates from fecal samples of pigs receiving tylosin as an antimicrobial growth promoter and 59 isolates obtained in the same farms 5 to 6 months after the ban of antimicrobial growth promoters in Switzerland were tested for susceptibility to nine antimicrobial agents. A clear decrease in resistance to macrolides, lincosamides, and tetracycline was visible after the ban. Vancomycin-resistant Enterococcus faecium belonged to the same clonal lineage as vancomycin-resistant isolates previously isolated from Danish pigs.

Cited by

• Food Animals and Antimicrobials: Impacts on Human Health

Related

• Agricultural Origins of a Highly Persistent Lineage of Vancomycin-Resistant Enterococcus faecalis in New Zealand
• Phenotypic and genotypic profiling of antimicrobial resistance in enteric Escherichia coli communities isolated from finisher pigs in Australia
• <i>Salmonella</i> and <i>Yersinia enterocolitica</i> through the pig meat chain in Sardinia: occurrence, antimicrobial resistance and genetic insight
• Antimicrobial resistance genes in Actinobacillus pleuropneumoniae , Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs
• Bacteriophage-mediated transduction of antibiotic resistance in enterococci